欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Relacorilant_1496510-51-0_产品详情
1496510-51-0
  • names:

    Relacorilant

  • CAS号:

    1496510-51-0

    MDL Number:
  • MF(分子式): C27H22F4N6O3S MW(分子量): 586.56
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Relacorilant
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM003706-250mg 250mg ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM003706-100mg 100mg >97% ¥ 0.00 ¥ 0.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1496510-51-0
Inchi
InchiKey
分子式 Formula C27H22F4N6O3S
分子量 Molecular Weight 586.56
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
Relacorilant(CAS:1496510-51-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Relacorilant 是一种有效的,选择性的,可口服的糖皮质激素受体 (glucocorticoid receptor) 拮抗剂,在 HepG2 TAT 实验中,Ki值为 7.2 nM,在细胞体系中,对大鼠,人和猴子糖皮质激素受体的Ki值分别为 12,81.2,210 nM;Relacorilant 已经进入临床 2 期来研究库欣综合征
IntroductionRelacorilant is a potent, selective and orally bioavailableglucocorticoid receptorantagonist, with aKiof 7.2 nM in HepG2 TAT assay, and also showsKis of 12, 81.2, 210 nM for rat, human and monkey glucocorticoid receptor in cellased assay, respectively; Relacorilant has entered phase 2 clinical study in patients with Cushing’s syndrome.
Application1
Application2
Application3
Relacorilant 是一种有效的,选择性的,可口服的糖皮质激素受体 (glucocorticoid receptor) 拮抗剂,在 HepG2 TAT 实验中,Ki值为 7.2 nM,在细胞体系中,对大鼠,人和猴子糖皮质激素受体的Ki值分别为 12,81.2,210 nM;Relacorilant 已经进入临床 2 期来研究库欣综合征。Relacorilant is a potent, selective and orally bioavailableglucocorticoid receptorantagonist, with aKiof 7.2 nM in HepG2 TAT assay, and also showsKis of 12, 81.2, 210 nM for rat, human and monkey glucocorticoid receptor in cell-based assay, respectively; Relacorilant has entered phase 2 clinical study in patients with Cushing’s syndrome.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Hunt HJ, et al. Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist. J Med Chem. 2017 Apr 27;60(8):3405-3421.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents